Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Urokinase-type plasminogen activator antigen and early relapse in breast cancer.

× No keyword cloud information.

38 in total

1. Timing of surgery during the menstrual cycle and prognosis of breast cancer.

Authors: R A Badwe; I Mittra; R Havaldar
Journal: J Biosci Date: 2000-03 Impact factor: 1.826

2. Experience in Phase I Trials and an Upcoming Phase II Study with uPA Inhibitors in Metastatic Breast Cancer.

Authors: Lori J Goldstein
Journal: Breast Care (Basel) Date: 2008-10-16 Impact factor: 2.860

3. The Oral Serine Protease Inhibitor WX-671 - First Experience in Patients with Advanced Head and Neck Carcinoma.

Authors: Jens E Meyer; Carsten Brocks; Hendrik Graefe; Carola Mala; Natalie Thäns; Markus Bürgle; Annette Rempel; Nicole Rotter; Barbara Wollenberg; Stephan Lang
Journal: Breast Care (Basel) Date: 2008-10-16 Impact factor: 2.860

4. Perspectives on Breast Cancer Management: Tailoring Treatment to the Individual Patient.

Authors: Christoph Thomssen
Journal: Breast Care (Basel) Date: 2008-04-25 Impact factor: 2.860

5. Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects.

Authors: Manfred Schmitt; Karin Mengele; Apostolos Gkazepis; Rudolf Napieralski; Viktor Magdolen; Ute Reuning; Nadia Harbeck
Journal: Breast Care (Basel) Date: 2008-10-15 Impact factor: 2.860

6. Prospective Biomarker Trials Chemo N0 and NNBC-3 Europe Validate the Clinical Utility of Invasion Markers uPA and PAI-1 in Node-Negative Breast Cancer.

Authors: Nadia Harbeck; Manfred Schmitt; Martina Vetter; Janna Krol; Daniela Paepke; Mathias Uhlig; Stefan Paepke; Fritz Jänicke; Anneke Geurts-Moespot; Gunter von Minckwitz; Fred Sweep; Christoph Thomssen
Journal: Breast Care (Basel) Date: 2008-10-16 Impact factor: 2.860

Review 7. The role of proteolytic enzymes in cancer invasion and metastasis.

Authors: M J Duffy
Journal: Clin Exp Metastasis Date: 1992-05 Impact factor: 5.150

8. Expression and localization of urokinase-type plasminogen activator in human spinal column tumors.

Authors: Z L Gokaslan; S K Chintala; J E York; V Boyapati; S Jasti; R Sawaya; G Fuller; D M Wildrick; G L Nicolson; J S Rao
Journal: Clin Exp Metastasis Date: 1998-11 Impact factor: 5.150

9. [The prognostic importance of urinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in the primary resection of oral squamous cell carcinoma].

Authors: B Hundsdorfer; H-F Zeilhofer; K P Bock; P Dettmar; M Schmitt; H-H Horch
Journal: Mund Kiefer Gesichtschir Date: 2004-02-06

10. [Comparison of urokinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in primary resection of oral squamous cell carcinoma].

Authors: B Hundsdorfer; H-F Zeilhofer; K P Bock; P Dettmar; M Schmitt; H-H Horch
Journal: Mund Kiefer Gesichtschir Date: 2004-02-06